Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference32 articles.
1. ‘Westernizing’ women's risks? Breast cancer in lower-income countries;Porter;N Engl J Med,2008
2. HER-2/neu as a predictive marker of response to breast cancer therapy;Pegram;Breast Cancer Res Treat,1998
3. Triple-negative breast cancer: therapeutic options;Cleator;Lancet Oncol,2007
4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
5. High-throughput protein expression analysis using tissue microarray technology of a large well characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses;Abd El-Rehim;Int J Cancer,2005
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating the effect of Avastin on breast cancer angiogenesis using synchrotron radiation;Quantitative Imaging in Medicine and Surgery;2019-03
2. Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer;Hematology/Oncology and Stem Cell Therapy;2015-03
3. Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer;Future Oncology;2014-02
4. Deregulated Serum Concentrations of Circulating Cell–Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression;Clinical Chemistry;2013-10-01
5. Elevated Serum IL-17A but not IL-6 in Glioma Versus Meningioma and Schwannoma;Asian Pacific Journal of Cancer Prevention;2013-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3